The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.
Julia C GageTina Raine-BennettMark SchiffmanMegan A ClarkeLi C CheungNancy E PoitrasNicole E VarnadoHormuzd A KatkiPhilip E CastleBrian BefanoMalini ChandraGreg RydzakThomas LoreyNicolas WentzensenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
The IRIS study is a unique and highly relevant resource allowing for natural history studies and rigorous evaluation of candidate HrHPV screening and triage markers, while permitting studies of biomarkers associated with other gynecological cancers.